SCALING BIOSIMILAR PRODUCTION WEBINAR
Rieckermann recently hosted the second session of their new webinar series, this time discussing the topic “Scaling Biosimilar Production: Technical Challenges & Considerations.” This session provided….
NEW ACQUISITION
Rieckermann is proud to welcome a new member to the Group. Effective Friday, February 14, 2025, JR New Horizons, Rieckermann’s independent investment arm, was able to acquire a renowned technology leader in …
EXPANDING SERVICE EXCELLENCE WITH NEW PARTNERSHIP
Rieckermann is pleased to embark on a new strategic partnership with Pamarco, a global leader in anilox products and services. This partnership will significantly expand both companies’ collective market presence and …
CONTRACT WITH VNVC VACCINE AND BIOLOGICAL MANUFACTURING JOINT STOCK COMPANY
Rieckermann is thrilled to announce the signing of a contract with the VNVC Vaccine And Biological Manufacturing Joint Stock Company to design their new vaccine and biological products manufacturing facility in Long An, Vietnam…
RIECKERMANN BIOREACTORS WEBINAR
Rieckermann is thrilled to have hosted an insightful webinar entitled “Bioreactors: The heart of biotechnology processes”, during which senior biotech specialist, Dr. Siew Leng Tai, provided a comprehensive technical review…
RIECKERMANN AT DUPHAT 2025
Rieckermann was excited to be part of the Dubai International Pharmaceuticals & Technologies Conference & Exhibition (DUPHAT) alongside industry partners De Lama and MG2. The exhibition booth was organized by…
